Non-Member: Missed a Webinar? $45 Access to 2021 and 2020 Recordings

Non-Member: $45 access per webinar recording
Member: $100 annual membership includes free access to all recordings

• 06/16/2021 Has Assignor Estoppel outlived its Usefulness?
• 05/26/2021 The Limits of Zealous Representation: Exceptional Case, Patent Misuse, and Antitrust
• 05/12/2021 How not to be an enabler: The implications of Amgen v. Sanofi and Regeneron for antibody claims and beyond
• 04/28/2021 Riding the 101 Wave – The Ebb and Flow of Patent Eligibility in the Courts and the PTO
• 04/14/2021 The requirement for sufficiency: how much is enough to enable claims to a range of products? Recent guidance from the UK Supreme Court in Regeneron v Kymab

• 03/15/2021 2020 at the Supreme Court: How the court impacted patent law despite issuing only a single patent case opinion
• 02/17/2021 The Impact of PTAB Proceedings on Bio/Pharma Litigation and Strategy
• 02/10/2021 Strategies to Leverage Recent PTAB Precedential Decisions
• 02/03/2021 Amending Patent Claims in PTAB Proceedings
• 01/27/2021 Examining the Latest Developments on the PTAB’s Use of Discretionary Denials

• 12/16/2020 Remote at the Federal Circuit, But Central to Pharma: Meeting the Enablement Requirement for Biotech Patents
• 12/09/2020 Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering
• 11/18/2020 Professional Responsibility and Practice Before the USPTO
• 10/07/2020 SPCs in Europe: News and Updates - All You Need to Know
• 09/30/2020 Presenting Before a District Court: The Importance of Being Earnest

• 08/25/2020 Recent Developments in Inducement and Divided Infringement
• 08/11/2020 Diagnosing what Ails Patent Eligibility: Can this Problem be Solved?
• 07/21/2020 A Behind the Scenes Look at a Supreme Court Argument and a Biotech Jury Trial
• 07/14/2020 Willful Infringement: Acts of Piracy
• 06/30/2020 Written Description and Enablement Issues in Pharma/Bio Patents – Latest Developments
• 06/16/2020 Patent Cases at the Supreme Court: From Petitions to CVSGs to Arguments, and Everything in Between